News + Filings Holdings
All
13F
13D/G
Other
|
|
Avidity Partners Management LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/25/2023 |
SC 13G
| Avidity Partners Management LP reports a 6.2% stake in NanoString Technologies, Inc. |
| 02/02/2023 |
SC 13G
| Avidity Partners Management LP reports a 8.7% stake in Praxis Precision Medicines, Inc. |
| 12/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/27/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/20/2022 |
SC 13G
| Avidity Partners Management LP reports a 9.9% stake in Syros Pharmaceuticals, Inc. |
| 09/16/2022 |
SC 13G
| Avidity Partners Management LP reports a 6.9% stake in Akero Therapeutics, Inc. |
| 06/16/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2022 |
SC 13G
| Avidity Partners Management LP reports a 5.5% stake in SeaSpine Holdings Corporation |
| 02/11/2022 |
SC 13G
| Avidity Partners Management LP reports a 6% stake in Phathom Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2022 |
SC 13G
| Avidity Partners Management LP reports a 6.7% stake in Zentalis Pharmaceuticals, Inc. |
| 01/03/2022 |
SC 13G
| Avidity Partners Management LP reports a 6.6% stake in Kezar Life Sciences, Inc. |
| 01/03/2022 |
SC 13G
| Avidity Partners Management LP reports a 7% stake in Altimmune Inc. |
| 12/01/2021 |
SC 13G
| Avidity Partners Management LP reports a 6.4% stake in IDEAYA Biosciences, Inc. |
| 10/25/2021 |
SC 13G
| Avidity Partners Management LP reports a 7% stake in IVERIC bio, Inc. |
| 03/22/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/30/2020 |
SC 13G
| Avidity Partners Management LP reports a 6% stake in Oncosec Medical Incorporated |
| 12/28/2020 |
SC 13G
| Avidity Partners Management LP reports a 9.9% stake in Gritstone Oncology, Inc. |
| 12/23/2020 |
SC 13G
| Avidity Partners Management LP reports a 9.9% stake in Scynexis, Inc. |
| 12/23/2020 |
SC 13G
| Avidity Partners Management LP reports a 5.6% stake in Alpine Immune Sciences, Inc. |
| 11/04/2020 |
SC 13G
| Avidity Partners Management LP reports a 6.7% stake in Syndax Pharmaceuticals, Inc. |
| 03/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|